WO2007026245A1 - Novel composition - Google Patents
Novel composition Download PDFInfo
- Publication number
- WO2007026245A1 WO2007026245A1 PCT/IB2006/002536 IB2006002536W WO2007026245A1 WO 2007026245 A1 WO2007026245 A1 WO 2007026245A1 IB 2006002536 W IB2006002536 W IB 2006002536W WO 2007026245 A1 WO2007026245 A1 WO 2007026245A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition according
- present
- flour
- amount
- dough
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 59
- 235000016709 nutrition Nutrition 0.000 claims abstract description 12
- 239000005715 Fructose Substances 0.000 claims abstract description 10
- 229930091371 Fructose Natural products 0.000 claims abstract description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 10
- 235000015895 biscuits Nutrition 0.000 claims description 35
- 235000013312 flour Nutrition 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 241000209140 Triticum Species 0.000 claims description 10
- 235000021307 Triticum Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 6
- 235000010855 food raising agent Nutrition 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000011844 whole wheat flour Nutrition 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 3
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 238000007493 shaping process Methods 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000008172 hydrogenated vegetable oil Substances 0.000 claims 1
- 230000002641 glycemic effect Effects 0.000 abstract description 21
- 230000001953 sensory effect Effects 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 24
- 239000008103 glucose Substances 0.000 description 24
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 235000011888 snacks Nutrition 0.000 description 13
- 235000014633 carbohydrates Nutrition 0.000 description 12
- 150000001720 carbohydrates Chemical class 0.000 description 11
- 230000004044 response Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 6
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 2
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 235000007558 Avena sp Nutrition 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 2
- 239000001099 ammonium carbonate Substances 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000000291 postprandial effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000611 regression analysis Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- 235000012794 white bread Nutrition 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000009118 appropriate response Effects 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D13/00—Finished or partly finished bakery products
- A21D13/80—Pastry not otherwise provided for elsewhere, e.g. cakes, biscuits or cookies
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/16—Fatty acid esters
- A21D2/165—Triglycerides
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/14—Organic oxygen compounds
- A21D2/18—Carbohydrates
- A21D2/181—Sugars or sugar alcohols
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/08—Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
- A21D2/24—Organic nitrogen compounds
- A21D2/26—Proteins
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to a palatable baked nutritional composition which has a low glycaemic index and low glycaemic load and improved sensory characteristics such as crispiness and mouthfeel.
- Compositions of the present invention are suitable as a snack for people who are seeking options without added sucrose and for those with diabetes.
- Diabetes is a metabolic disorder wherein the main problem is that the glucose in the blood does not get cleared at a normal rate leading to elevated blood glucose levels. This has been linked to the hormone insulin.
- type 1 diabetes the body is unable to produce insulin. Onset of type 1 diabetes usually starts in childhood or young adulthood. In type 2 diabetes, not enough insulin is produced or the insulin that is produced doesn't effect the appropriate response. Type 2 diabetes tends to affect people as they get older. In both types the result is an inability to control blood glucose levels, leading to hyperglycaemia.
- Hyperglycaemia is the cause of symptoms associated with diabetes, such as polydypsia, polyuria and polyphagia and may contribute to the development of macrovascular disease, which is associated with the development of coronary artery disease. Since the body is unable to control the level of blood glucose, a major aspect of life for a person with diabetes is to manage blood glucose levels as close to normal as possible. Control of diet, in particular distribution of carbohydrate and sugar, in meals throughout the day is therefore of importance.
- WO 97/38593 describes a supplement bar for the prevention of night time hypoglycaemia which includes simple and complex carbohydrates, proteins and lipids.
- the compositions comprise uncooked corn starch.
- US 6,248,375 describes a solid matrix composition designed for the person with diabetes comprising a carbohydrate system utilising a source of fructose in combination with a nonabsorbent carbohydrate to produce a glycaemic response comparable to more complex multi-component carbohydrate systems.
- a palatable nutritional composition for example a biscuit product, which will not result in the abnormal elevation of blood glucose levels and will provide a healthy nutritional and tasty snack for people who have diabetes.
- Snack foods such as biscuits normally contain sugar (sucrose) as the sweetener and also for providing the desired texture and physical properties.
- sugar sucrose
- a problem observed with no or low added sucrose products is that they have poor mouthfeel and generally retain moisture resulting in lack of crispiness and other undesirable properties.
- GI glycaemic index
- GL glycaemic load
- a palatable short dough nutritional crispy biscuit can be prepared by using fructose and fibre in combination with protein, fat, extruded crispy particles and enzymes.
- the present invention provides a short dough crispy texture nutritional biscuit composition
- a short dough crispy texture nutritional biscuit composition comprising
- compositions of the present invention comprise fructose from 3.0 to 12.0 % w/w, suitably from 4.0 to 10.0 % w/w and more suitably from 6.0 to 8.0 % w/w.
- Fructose provides sweetness whilst avoiding the negative effects of elevated blood glucose levels.
- Compositions of the present invention further comprise natural fibre from 1 to 8% w/w, suitably from 1.5 to 6.0 % w/w, and more suitably from 2.0 to 3.5 % w/w.
- Fibre serves not only to provide a nutritional value but also helps to retain integrity and reduce breakage by binding the ingredients.
- Suitable sources of fibre include wheat fibre, oat fibre, fruit fibre, vegetable fibre and wheat bran and mixtures thereof.
- Compositions of the present invention further comprise protein isolate from 0.5 to 6.0 % w/w, suitably from 1.0 to 4.0 % w/w and more suitably from 1.5 to 2.5 % w/w.
- Suitable sources of protein isolate include soy protein, whey protein, cereal protein and legume protein and mixtures thereof.
- Compositions of the present invention further comprise fat from 12.0 to 28.0 % w/w, suitably from 14.0 to 25.0 % and more suitably from 15.0 to 20.0 % w/w.
- the level of fat used in the composition is important for the shortening characteristics and hence contributes to the crispiness.
- Suitable sources of fat include hydrogenated vegetable fat, unhydrogenated vegetable fat and interesterified fat.
- Suitable sources of hydrogenated fat include corn oil, soy oil, palm oil, coconut oil, peanut oil and sunflower oil and mixtures thereof.
- compositions of the present invention include crispy particles from 0.5 to 10.0 % w/w, suitably from 2.0 to 7.0 % w/w and more suitably from 4.0 to 6.0 % w/w.
- the inclusion of crispy particles contributes to the crispy texture.
- Crispy particles may be made from refined wheat flour, whole wheat flour, oat flour, rice flour and soy flour and mixtures thereof.
- Crispy particles for use in compositions of the present invention may be made by an extrusion process.
- compositions of the present invention comprise flour from 50.0 to 70.0 % w/w, suitably 53.0 to 63.0 % w/w and more suitably 55.0 to 60.0 % w/w.
- Suitable sources of flour may be selected from refined wheat flour, whole wheat flour, oat flour, rice flour and soy flour and mixtures thereof.
- compositions of the present invention will comprise emulsifier from 1.0 % w/w to 3.5 % w/w, suitably 2.5 % w/w to 3.5% w/w.
- Suitable emulsifiers include soy lecithin and glycerol monosterate and mixtures thereof.
- compositions of the present invention may also comprise milk powder from 0 to 10.0 % w/w, suitably 2.0 to 8.0 % w/w and more suitably 3.0 to 6.0 % w/w.
- Other ingredients used in the preparation of compositions of the present invention include enzymes and leavening agents.
- enzymes are added during processing at from 0.06 to 0.14% w/w of the total ingredients.
- the purpose of the enzymes is to control the moisture, surface finish and texture and gluten level in the dough mixture. Suitable enzymes include protease and xylanase and mixtures thereof.
- leavening agents are added during processing at from 0.5 to 1.5 % w/w of the total ingredients.
- Suitable leavening agents include sodium bicarbonate, ammonium bicarbonate and monoacid calcium phosphate and mixtures thereof.
- compositions of the present invention may be used in the preparation of compositions of the present invention such as artificial sweeteners, salt, flavours, preservatives, vitamins and minerals.
- Minerals are suitably in the form of salts of elements such as calcium, iron and zinc.
- compositions of the present invention are made from the following ingredients and ratios:
- Refined wheat flour Whole wheat flour crispy particles from 6:1 to 20:1, suitably 9:1 to 15 : 1 and more suitably 12: 1 to 14: 1.
- Refined wheat flour Enzymes from 14000:1 to 3000:1, suitably 9000:1 to 4000:1, more suitably 6000:1 to 4500:1.
- compositions of the present invention suitably contain the enzymes protease and xylanase in the ratio from 1:1 to 1:2, more suitably 1:1.2.
- compositions of the present invention suitably contain the leavening agents sodium bicarbonate, ammonium bicarbonate and monoacid calcium phosphate in the ratio 0.4:1:0.25.
- Biscuit compositions of the present invention may be made by the following process: a) mixing the emulsifier with a sufficient amount of fat at 65°C to75°C to form a paste; b) mixing the paste from step a) with the remaining fat at a temperature not exceeding 45 0 C; c) adding the crispy particles to the mixture from step b); d) adding the protein isolate and fibre to the mixture from step c); e) preparing a mixture of the fructose and other optional ingredients in water; f) adding enzyme and leavening agent in water to the mixture from step e); g) adding the flour to the mixture from step f); h) forming a dough from the mixtures from steps d) and g); i) shaping the dough from step h) into biscuit shapes; k) baking the dough from step i) at
- glycaemic index is the increase in blood glucose (over the fasting level) that is observed in the two-hours following the ingestion of a set amount of carbohydrate in an individual food.
- Glycaemic load is the product of the glycaemic index of the food and the amount of carbohydrate in a serving (Sheard, N. F. et al, Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes. A Statement by the American Diabetes Association. Diabetes Care, Volume 29, No 9, September 2004, 2226-2271).
- a high GI value is 70 or more, a medium GI value is in the range 56-69 inclusive and low GI value is 55 or less.
- a high GL is 20 or more, a medium GL value is in the range of 11-19 inclusive and low GL value is in the range of 10 or less.
- the glycaemic index for a short dough biscuit according to the invention was determined by comparing the glycaemic response to the short dough biscuit with the response to 50g of glucose in 14 healthy volunteers after an overnight fast.
- Each study subject underwent three study phases for glucose and one for the short dough biscuit. At each phase the subject was given either a standard 5Og glucose solution in 300ml of water or a serving of test biscuit to provide a 50g carbohydrate equivalent (11 biscuits). The study phases for each volunteer were randomised. This is in conformance to the globally accepted FAO/WHO protocol for Glycaemia Index testing. All necessary institutional procedures were followed and the study was carried out under the supervision of a diabetologist, at a unit in a hospital.
- the mean Glycaemic Index for the biscuits was 38 [+ 17].
- the glycaemic response to a short dough biscuit according to the invention was compared to that of an iso-caloric reference snack (white bread sandwich), in patients with mild to moderate type 2 diabetes.
- the patients were either on diet therapy or on oral hypoglycaemic drugs or a combination of both.
- Each subject had to undergo two study phases, one for the reference sandwich and one for the short dough biscuit. At each phase the subject was given either the reference sandwich or the biscuits (3 biscuits) with 200ml of water. The study phases for each volunteer were randomised. All necessary institutional procedures were followed and the study was carried out under the supervision of a diabetologist, at a diabetes unit in a hospital.
- the incremental blood glucose value for the test product was lower than for the reference snack, but the difference was not found to be statistically significant at any time point.
- the mean two hour post prandial capillary blood glucose value was below 180mg/dl in conformance with the American Diabetes Association guidelines.
- the mean IAUC for venous blood glucose over a period of 3 hrs for the reference snack and biscuits was 3018.12 ⁇ 1462.83 and 2544.87 ⁇ 2127.93 respectively. There was no significant difference in IAUC of biscuits as compared to the reference snack.
- the data suggest that the glycaemic response for the test product (biscuits), was lower than for the reference snack (the bread sandwich). Statistically there was no difference and the response was comparable to that from a standard sandwich snack in patients with type 2 diabetes. Based on the acute glycaemic profile, in its recommended serve size, the short dough biscuit is suitable for consumption by people with type 2 diabetes.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
Abstract
The present invention relates to a palatable baked nutritional composition comprising fructose which has a low glycaemic index and low glycaemic load and improved sensory characteristics such as crispiness and mouthfeel.
Description
Novel Composition
The present invention relates to a palatable baked nutritional composition which has a low glycaemic index and low glycaemic load and improved sensory characteristics such as crispiness and mouthfeel. Compositions of the present invention are suitable as a snack for people who are seeking options without added sucrose and for those with diabetes.
Diabetes is a metabolic disorder wherein the main problem is that the glucose in the blood does not get cleared at a normal rate leading to elevated blood glucose levels. This has been linked to the hormone insulin. There are two main types of diabetes. In type 1, the body is unable to produce insulin. Onset of type 1 diabetes usually starts in childhood or young adulthood. In type 2 diabetes, not enough insulin is produced or the insulin that is produced doesn't effect the appropriate response. Type 2 diabetes tends to affect people as they get older. In both types the result is an inability to control blood glucose levels, leading to hyperglycaemia. Hyperglycaemia is the cause of symptoms associated with diabetes, such as polydypsia, polyuria and polyphagia and may contribute to the development of macrovascular disease, which is associated with the development of coronary artery disease. Since the body is unable to control the level of blood glucose, a major aspect of life for a person with diabetes is to manage blood glucose levels as close to normal as possible. Control of diet, in particular distribution of carbohydrate and sugar, in meals throughout the day is therefore of importance.
WO 97/38593 describes a supplement bar for the prevention of night time hypoglycaemia which includes simple and complex carbohydrates, proteins and lipids. The compositions comprise uncooked corn starch.
US 6,248,375 describes a solid matrix composition designed for the person with diabetes comprising a carbohydrate system utilising a source of fructose in combination with a nonabsorbent carbohydrate to produce a glycaemic response comparable to more complex multi-component carbohydrate systems.
There remains a need to provide a palatable nutritional composition, for example a biscuit product, which will not result in the abnormal elevation of blood glucose levels and will provide a healthy nutritional and tasty snack for people who have diabetes.
Snack foods, such as biscuits normally contain sugar (sucrose) as the sweetener and also for providing the desired texture and physical properties. Clearly for the diabetic patient, it is appropriate that such snacks are replaced with those having no or low added sucrose. However, a problem observed with no or low added sucrose products is that they have poor mouthfeel and generally retain moisture resulting in lack of crispiness and other undesirable properties.
It is an object of this invention to provide a nutritional biscuit which has a low glycaemic index (GI) and glycaemic load (GL) whilst retaining crispiness and mouthfeel.
It has now been found that a palatable short dough nutritional crispy biscuit can be prepared by using fructose and fibre in combination with protein, fat, extruded crispy particles and enzymes.
Accordingly the present invention provides a short dough crispy texture nutritional biscuit composition comprising
(a) fructose from 3.0 to 12.0 % w/w;
(b) natural fibre from 1.0 to 8.0 % w/w;
(c) protein isolate from 0.5 to 6.0 % w/w; (d) fat from 12 to 28.0 % w/w;
(e) flour from 50.0 to 70.0 % w/w;
(f) crispy particles from 0.5 to 10.0 % w/w;
(g) emulsifier from 1.0 to 3.5 % w/w.
Compositions of the present invention comprise fructose from 3.0 to 12.0 % w/w, suitably from 4.0 to 10.0 % w/w and more suitably from 6.0 to 8.0 % w/w. Fructose provides sweetness whilst avoiding the negative effects of elevated blood glucose levels.
Compositions of the present invention further comprise natural fibre from 1 to 8% w/w, suitably from 1.5 to 6.0 % w/w, and more suitably from 2.0 to 3.5 % w/w. Fibre serves not only to provide a nutritional value but also helps to retain integrity and reduce breakage by binding the ingredients. Suitable sources of fibre include wheat fibre, oat fibre, fruit fibre, vegetable fibre and wheat bran and mixtures thereof.
Compositions of the present invention further comprise protein isolate from 0.5 to 6.0 % w/w, suitably from 1.0 to 4.0 % w/w and more suitably from 1.5 to 2.5 % w/w. Suitable sources of protein isolate include soy protein, whey protein, cereal protein and legume protein and mixtures thereof.
Compositions of the present invention further comprise fat from 12.0 to 28.0 % w/w, suitably from 14.0 to 25.0 % and more suitably from 15.0 to 20.0 % w/w. The level of fat used in the composition is important for the shortening characteristics and hence contributes to the crispiness. Suitable sources of fat include hydrogenated vegetable fat, unhydrogenated vegetable fat and interesterified fat. Suitable sources of hydrogenated fat include corn oil, soy oil, palm oil, coconut oil, peanut oil and sunflower oil and mixtures thereof.
Compositions of the present invention include crispy particles from 0.5 to 10.0 % w/w, suitably from 2.0 to 7.0 % w/w and more suitably from 4.0 to 6.0 % w/w. The inclusion of crispy particles contributes to the crispy texture. Crispy particles may be made from refined wheat flour, whole wheat flour, oat flour, rice flour and soy flour and mixtures thereof. Crispy particles for use in compositions of the present invention may be made by an extrusion process.
Compositions of the present invention comprise flour from 50.0 to 70.0 % w/w, suitably 53.0 to 63.0 % w/w and more suitably 55.0 to 60.0 % w/w. Suitable sources of flour may be selected from refined wheat flour, whole wheat flour, oat flour, rice flour and soy flour and mixtures thereof.
Compositions of the present invention will comprise emulsifier from 1.0 % w/w to 3.5 % w/w, suitably 2.5 % w/w to 3.5% w/w. Suitable emulsifiers include soy lecithin and glycerol monosterate and mixtures thereof.
Compositions of the present invention may also comprise milk powder from 0 to 10.0 % w/w, suitably 2.0 to 8.0 % w/w and more suitably 3.0 to 6.0 % w/w.
Other ingredients used in the preparation of compositions of the present invention include enzymes and leavening agents. Suitably enzymes are added during processing at from 0.06 to 0.14% w/w of the total ingredients. The purpose of the enzymes is to control the moisture, surface finish and texture and gluten level in the dough mixture. Suitable enzymes include protease and xylanase and mixtures thereof.
Suitably, leavening agents are added during processing at from 0.5 to 1.5 % w/w of the total ingredients. Suitable leavening agents include sodium bicarbonate, ammonium bicarbonate and monoacid calcium phosphate and mixtures thereof.
Other ingredients commonly used in nutritional products may be used in the preparation of compositions of the present invention such as artificial sweeteners, salt, flavours, preservatives, vitamins and minerals. Minerals are suitably in the form of salts of elements such as calcium, iron and zinc.
Preferred compositions of the present invention are made from the following ingredients and ratios:
1. Refined wheat flour : Whole wheat flour crispy particles from 6:1 to 20:1, suitably 9:1 to 15 : 1 and more suitably 12: 1 to 14: 1.
2. Refined wheat flour & Whole wheat flour crispy particles : vegetable oil from 3.1 to 3.5:1 .
3. Refined wheat flour : Enzymes from 14000:1 to 3000:1, suitably 9000:1 to 4000:1, more suitably 6000:1 to 4500:1.
Compositions of the present invention suitably contain the enzymes protease and xylanase in the ratio from 1:1 to 1:2, more suitably 1:1.2.
Compositions of the present invention suitably contain the leavening agents sodium bicarbonate, ammonium bicarbonate and monoacid calcium phosphate in the ratio 0.4:1:0.25.
Biscuit compositions of the present invention may be made by the following process: a) mixing the emulsifier with a sufficient amount of fat at 65°C to75°C to form a paste; b) mixing the paste from step a) with the remaining fat at a temperature not exceeding 450C; c) adding the crispy particles to the mixture from step b); d) adding the protein isolate and fibre to the mixture from step c); e) preparing a mixture of the fructose and other optional ingredients in water; f) adding enzyme and leavening agent in water to the mixture from step e); g) adding the flour to the mixture from step f); h) forming a dough from the mixtures from steps d) and g); i) shaping the dough from step h) into biscuit shapes; k) baking the dough from step i) at a temperature in the range 180 to 35O0C.
For the avoidance of doubt, glycaemic index (GI) is the increase in blood glucose (over the fasting level) that is observed in the two-hours following the ingestion of a set amount of carbohydrate in an individual food. Glycaemic load (GL) is the product of the glycaemic index of the food and the amount of carbohydrate in a serving (Sheard, N. F. et al, Dietary Carbohydrate (Amount and Type) in the Prevention and Management of Diabetes. A Statement by the American Diabetes Association. Diabetes Care, Volume 29, No 9, September 2004, 2226-2271). As per international guidelines, a high GI value is 70 or more, a medium GI value is in the range 56-69 inclusive and low GI value is 55 or less. A high GL is 20 or more, a medium GL value is in the range of 11-19 inclusive and low GL value is in the range of 10 or less.
The invention is illustrated by way of the following examples:
1. Glycaemic Index - Short Dough Biscuit in Healthy Volunteers.
The glycaemic index for a short dough biscuit according to the invention was determined by comparing the glycaemic response to the short dough biscuit with the response to 50g of glucose in 14 healthy volunteers after an overnight fast.
Methodology
Each study subject underwent three study phases for glucose and one for the short dough biscuit. At each phase the subject was given either a standard 5Og glucose solution in 300ml of water or a serving of test biscuit to provide a 50g carbohydrate equivalent (11 biscuits). The study phases for each volunteer were randomised. This is in conformance to the globally accepted FAO/WHO protocol for Glycaemia Index testing. All necessary institutional procedures were followed and the study was carried out under the supervision of a diabetologist, at a unit in a hospital.
Blood Sampling
For each study phase eight venous blood samples were collected at t = -15, 0, 15, 30, 45, 60, 90 and 120 minutes. Blood glucose levels were measured.
Blood glucose levels were plotted against time to calculate the incremental area under the curve (IAUC) for each study phase. The GI was calculated for each volunteer as the incremental area under the curve for the biscuit divided by the mean incremental area under the curve for the 3 glucose tests. The mean GI of all the volunteers was a measure of the GI for the biscuit .
Results
The mean Glycaemic Index for the biscuits was 38 [+ 17]. The Glycaemic Load (GI x Carbohydrate per serve / 100) for a serve size of 21.4g (3 biscuits), was 5.
1. Nutritional Composition of Biscuits per lOOg (14 biscuits), 8Og (11 biscuits) & 21.4g (3 biscuits).
The glycaemic response to a short dough biscuit according to the invention was compared to that of an iso-caloric reference snack (white bread sandwich), in patients with mild to moderate type 2 diabetes. The patients were either on diet therapy or on oral hypoglycaemic drugs or a combination of both.
Study design Prospective, single centre, randomised, comparative, cross over trial. All products were iso-caloric and the sequence of feeding was randomised.
Study Compositions
A. White bread sandwich, approximately 4Og bread with mint chutney (94 kcal, 19.5g carbohydrate).
B. 3 Short dough biscuits 21.4g (101 kcal, 13.39g carbohydrate)
Study Size
17 patients (9 male and 8 female) completed all the study periods.
Methodology
Each subject had to undergo two study phases, one for the reference sandwich and one for the short dough biscuit. At each phase the subject was given either the reference sandwich or the biscuits (3 biscuits) with 200ml of water. The study phases for each volunteer were randomised. All necessary institutional procedures were followed and the study was carried out under the supervision of a diabetologist, at a diabetes unit in a hospital.
Blood Sampling
Seven venous blood samples were taken at t = 0, 30, 60, 90, 120, 150 and 180 minutes, Five capillary blood samples were taken at t = 0, 30, 60, 120 and 180 minutes. The blood samples were analysed for glucose and for triglycerides to provide: a) Incremental glucose response over the course of 3 hours, b) 2h post prandial capillary glucose concentration,
c) Plasma triglyceride concentration 3h after consumption.
The incremental area under the blood glucose curve after the consumption of the test product was compared with that of the reference snack. For each individual, the glycaemic response was plotted on a graph. For the whole group the results were shown as mean ± standard error of mean.
The mean glycaemic (venous and capillary) and triglyceride response after the test product was compared with the response to the reference snack by Repeated Measures Regression Analysis using generalised estimating equation. Paired "t" test for the mean incremental blood glucose value at different time points and incremental area under the curve.
Results
The incremental blood glucose value for the test product was lower than for the reference snack, but the difference was not found to be statistically significant at any time point. The mean two hour post prandial capillary blood glucose value was below 180mg/dl in conformance with the American Diabetes Association guidelines.
Although the values for the test product were lower than the reference snack, results of the regression analysis for values over a period of 3 hours, showed no significant difference in the venous blood glucose values, capillary blood glucose values and triglyceride values for the biscuits compared to values for the standard sandwich.
The mean IAUC for venous blood glucose over a period of 3 hrs for the reference snack and biscuits was 3018.12 ± 1462.83 and 2544.87 ± 2127.93 respectively. There was no significant difference in IAUC of biscuits as compared to the reference snack.
Clinically, the data suggest that the glycaemic response for the test product (biscuits), was lower than for the reference snack (the bread sandwich). Statistically there was no difference and the response was comparable to that from a standard sandwich snack in patients with type 2 diabetes. Based on the acute glycaemic profile, in its recommended serve size, the short dough biscuit is suitable for consumption by people with type 2 diabetes.
Claims
1. A short dough crispy texture nutritional biscuit composition comprising
(a) fructose from 3.0 to 12.0 % w/w;
(b) natural fibre from 1.0 to 8.0 % w/w; (c) protein isolate from 0.5 to 6.0 % w/w;
(d) fat from 12 to 28.0 % w/w;
(e) flour from 50.0 to 70.0 % w/w;
(f) crispy particles from 0.5 to 10.0 % w/w;
(g) emulsifier from 1.0 to 3.5 % w/w.
2. A composition according to claim 1 wherein fructose is present in an amount from 6.0 to 8.0% w/w.
3. A composition according to claim 1 or 2 wherein the natural fibre is present in an amount from 2.0 to 3.5 % w/w.
4. A composition according any one of claims 1 to 3 wherein the protein isolate is present in amount from 1.5 to 2.5% w/w.
5. A composition according to any one of claims 1 to 4 wherein the fat is hydro genated vegetable oil and is present in an amount from 14.0 to 25.0% w/w.
6. A composition according to any one of claims 1 to 5 wherein the flour is present in an amount from 53 to 63% w/w.
7. A composition according to any one of claims 1 to 6 wherein the crispy particles are present in an amount from 2.0 to 7.0% w/w.
8. A composition according to any one of claims 1 to 8 wherein the ratio of refined wheat flour to whole wheat flour crispy particles in from 6 : 1 to 20 : 1.
9. A composition according to any one of claims 1 to 9 wherein the ratio of refined wheat flour and whole wheat crispies to vegetable oil is from 3.1 to 3.5 : 1.
10. A composition according to any one of claims 1 to 9 wherein the ratio of refined wheat flour to enzyme is from 14000 : 1 to 3000 : 1.
11. A process for the preparation of a short dough crispy texture nutritional biscuit composition according to claim 1 comprising the steps of: a) mixing the emulsifier with a sufficient amount of fat at 650C to75°C to form a paste; b) mixing the paste from step a) with the remaining fat at a temperature not exceeding 45°C; c) adding the crispy particles to the mixture from step b); d) adding the protein isolate and fibre to the mixture from step c); e) preparing a mixture of the fructose and other optional ingredients in water; f) adding enzyme and leavening agent in water to the mixture from step e); g) adding the flour to the mixture from step f); h) forming a dough from the mixtures from steps d) and g); i) shaping the dough from step h) into biscuit shapes; k) baking the dough from step i) at a temperature in the range 180 to 350°C.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN807KO2005 | 2005-09-02 | ||
IN807/KOL/2005 | 2005-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007026245A1 true WO2007026245A1 (en) | 2007-03-08 |
Family
ID=37487595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/002536 WO2007026245A1 (en) | 2005-09-02 | 2006-08-30 | Novel composition |
Country Status (2)
Country | Link |
---|---|
HK (1) | HK1101657A2 (en) |
WO (1) | WO2007026245A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018077985A1 (en) * | 2016-10-25 | 2018-05-03 | Generale Biscuit | High-protein biscuit |
CN109843070A (en) * | 2016-10-25 | 2019-06-04 | 大众饼干公司 | High protein biscuit |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017286A1 (en) * | 1996-10-21 | 1998-04-30 | Children's Hospital Of Los Angeles | Therapeutic food composition and method to diminish blood sugar fluctuations |
US6248375B1 (en) * | 2000-03-14 | 2001-06-19 | Abbott Laboratories | Diabetic nutritionals and method of using |
-
2006
- 2006-08-29 HK HK06109615A patent/HK1101657A2/en not_active IP Right Cessation
- 2006-08-30 WO PCT/IB2006/002536 patent/WO2007026245A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998017286A1 (en) * | 1996-10-21 | 1998-04-30 | Children's Hospital Of Los Angeles | Therapeutic food composition and method to diminish blood sugar fluctuations |
US6248375B1 (en) * | 2000-03-14 | 2001-06-19 | Abbott Laboratories | Diabetic nutritionals and method of using |
Non-Patent Citations (4)
Title |
---|
AKGÜN, S. ET AL.: "A comparison of carbohydrate metabolism after sucrose, sorbitol, and fructose meals in normal and diabetic subjects", DIABETES CARE, vol. 3, no. 5, October 1980 (1980-10-01), pages 582 - 585, XP009076059 * |
KOIVISTO, V.A.; YKI-JARVINEN, H.: "Fructose and insulin sensitivity in patients with type 2 diabetes", JOURNAL OF INTERNAL MEDICINE, vol. 233, 1993, pages 145 - 153, XP009076060 * |
PAINTER J E ET AL: "THE EFFECTS OF VARIOUS PROTEIN AND CARBOHYDRATE IN ENERGY BARS ON BLOOD GLUCOSE LEVELS IN HUMANS", CEREAL FOODS WORLD, AMERICAN ASSOCIATION OF CEREAL CHEMISTS, ST. PAUL, MN, US, vol. 47, no. 6, June 2002 (2002-06-01), pages 236 - 241, XP009048636, ISSN: 0146-6283 * |
PYLER, E.J.: "Baking science and technology", 1988, SOSLAND PUBLISHING, KANSAS CITY, USA, PAGES 477-478, 1012-1021, XP002411345 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018077985A1 (en) * | 2016-10-25 | 2018-05-03 | Generale Biscuit | High-protein biscuit |
CN109843070A (en) * | 2016-10-25 | 2019-06-04 | 大众饼干公司 | High protein biscuit |
JP2019528790A (en) * | 2016-10-25 | 2019-10-17 | ジェネラル ビスケット | High protein biscuits |
Also Published As
Publication number | Publication date |
---|---|
HK1101657A2 (en) | 2007-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2269334C (en) | Therapeutic food composition and method to diminish blood sugar fluctuations | |
EP3497210A1 (en) | Novel glucose oxidase compositions | |
US20070151569A1 (en) | Methods for achieving and maintaining weight loss | |
WO2013079084A1 (en) | Bakery product and method for the preparation thereof | |
WO2000057711A1 (en) | High protein edible compositions and method of preparing the same | |
WO2018029705A1 (en) | Novel glucose oxidase compositions | |
WO2002052945A1 (en) | Highly nutritious baked products | |
MXPA06013616A (en) | Food compositions containing creatine. | |
BR112012000691B1 (en) | BAKERY PRODUCT, COMPOSITION OF AN ANHID MIXTURE, COMPOSITION OF A CONCENTRATED ANHID MIXTURE, PROCESS FOR THE PREPARATION OF A BAKERY PRODUCT AND USE OF A COMPOSITION OF AN ANCHID MIXTURE OR A CONCENTRATE MIXTURE | |
US20040137112A1 (en) | Low glycemic index food | |
US8568820B2 (en) | Method of treating carbohydrate rich foods for reducing their glycemic indicies | |
Henry et al. | The glycaemic index: concept, recent developments and its impact on diabetes and obesity | |
Toeller et al. | Nutrition in the etiology and management of type 2 diabetes | |
Dorchy | Dietary management for children and adolescents with diabetes mellitus: personal experience and recommendations | |
WO2007026245A1 (en) | Novel composition | |
JP2013244012A (en) | Baked confectionery (chocolate cake) controlling rapid increase of blood sugar level for collecting contribution money for tohoku and method of manufacturing same | |
IT201900001031A1 (en) | Method for preparing gluten-free baked food products | |
Sharma et al. | Evaluation of fiber enriched biscuits as a healthy snack | |
AU7873194A (en) | Psyllium containing snack bars, processes for making these, and uses thereof | |
US20090123580A1 (en) | Methods for treating obesity, insulin resistance and inducing satiety | |
US20120022017A1 (en) | Composition and a method thereof | |
KR102374827B1 (en) | High protein cookie for diabetes | |
US20110268836A1 (en) | Food compositions | |
HU226088B1 (en) | Diabetic flour, flourmix and admixture free from bran and process for producing of baking product especially bread, rolls and cake and using these | |
Ramaswamy et al. | Preparation of Bakery Products Using Coconut Flour and Glycemic Response on Normal Healthy Adults |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 616/KOLNP/2008 Country of ref document: IN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06779990 Country of ref document: EP Kind code of ref document: A1 |